Literature DB >> 18980963

Ixabepilone in metastatic breast cancer: complement or alternative to taxanes?

Antoinette R Tan1, Deborah L Toppmeyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980963     DOI: 10.1158/1078-0432.CCR-07-4704

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  3 in total

1.  Molecular and functional characterization of myxobacteria isolated from soil in India.

Authors:  Shiv Kumar; Arun Kumar Yadav; Priyanka Chambel; Ramandeep Kaur
Journal:  3 Biotech       Date:  2017-05-31       Impact factor: 2.406

2.  CCR 20th anniversary commentary: BMS-247550—microtubule stabilization as successful targeted therapy.

Authors:  Navjotsingh Pabla; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2015-03-15       Impact factor: 12.531

Review 3.  Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer.

Authors:  Arijit Nath; Soham Mitra; Tanuma Mistry; Ranita Pal; Vilas D Nasare
Journal:  Med Oncol       Date:  2021-11-23       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.